Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dyskinesia, Drug-Induced”

83 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 83 results

Testing effectiveness (Phase 2)Study completedNCT02657681
What this trial is testing

Prevention of Levodopa-induced Dyskinesias by Transcranial Static Magnetic Field Stimulation (tSMS)

Who this might be right for
Dyskinesia, Medication-InducedParkinson's Disease
Fundación de investigación HM 50
Post-approval studies (Phase 4)Study completedNCT00926965
What this trial is testing

Tardive Dyskinesia and Cognitive Function

Who this might be right for
Tardive DyskinesiaNeurocognitive Function
Taipei Veterans General Hospital, Taiwan 80
Post-approval studies (Phase 4)Study completedNCT00164242
What this trial is testing

Treatment of Tardive Dyskinesia With Galantamine

Who this might be right for
Tardive Dyskinesia
Caroff, Stanley N., M.D. 36
Large-scale testing (Phase 3)Study completedNCT00672373
What this trial is testing

Extract of Ginkgo Biloba and Tardive Dyskinesia

Who this might be right for
Tardive DyskinesiaSchizophrenia
Beijing HuiLongGuan Hospital 157
Not applicableEnded earlyNCT02524886
What this trial is testing

Deep Brain Stimulation for Patients With Tardive Dyskinesia and or Dystonia

Who this might be right for
Tardive DyskinesiaTardive Dystonia
GGZ Centraal 1
Large-scale testing (Phase 3)Study completedNCT03176771
What this trial is testing

Efficacy and Safety of MT-5199 in Subjects With Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Tanabe Pharma Corporation 256
Post-approval studies (Phase 4)Study completedNCT03681574
What this trial is testing

Gabapentin as Preanesthetic Medication to Fast Procedures in Pediatric´s Oncology

Who this might be right for
Pain, PostoperativeAgitation States as Acute Reaction to Exceptional StressAnesthesia+1 more
Hospital Infantil Albert Sabin 135
Early research (Phase 1)WithdrawnNCT05053321
What this trial is testing

Reduction of Demoralization in Patients With Tardive Dyskinesia After Treatment With Valbenazine

Who this might be right for
Tardive Dyskinesia
Yale University
Post-approval studies (Phase 4)Study completedNCT03891862
What this trial is testing

Persistence of Effect and Safety of Valbenazine for the Treatment of Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia (TD)
Neurocrine Biosciences 135
Not applicableLooking for participantsNCT06570824
What this trial is testing

RTMS as an Intervention for Levodopa-induced Dyskinesia

Who this might be right for
Dyskinesia, Drug-InducedParkinson Disease
Danish Research Centre for Magnetic Resonance 68
Not applicableLooking for participantsNCT06011408
What this trial is testing

Remote Monitoring and Detecting of Tardive Dyskinesia for Improving Patient Outcomes

Who this might be right for
Tardive Dyskinesia
iRxReminder 300
Large-scale testing (Phase 3)Ended earlyNCT05116813
What this trial is testing

Open-label Safety Study of Dipraglurant (ADX48621) in Patients With Parkinson's Disease Receiving Levodopa-based Therapy

Who this might be right for
Parkinson DiseaseDyskinesia, Drug-InducedDyskinesias
Addex Pharma S.A. 17
Testing effectiveness (Phase 2)Study completedNCT01092065
What this trial is testing

Efficacy and Safety of AFQ056 When Combined With Increased Doses of L-dopa in Parkinson's Disease Patients With Moderate-severe L-dopa Induced Dyskinesia

Who this might be right for
Parkinson's Disease
Novartis 23
Testing effectiveness (Phase 2)Study completedNCT01688037
What this trial is testing

NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)

Who this might be right for
Tardive Dyskinesia
Neurocrine Biosciences 109
Post-approval studies (Phase 4)Looking for participantsNCT03495024
What this trial is testing

Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates

Who this might be right for
SchizophreniaSchizoaffective DisorderTobacco Smoking+2 more
Corporal Michael J. Crescenz VA Medical Center 10
Testing effectiveness (Phase 2)WithdrawnNCT02064010
What this trial is testing

Trial Evaluating SNC-102 in Drug-Induced Tardive Dyskinesia

Who this might be right for
Drug-induced Tardive Dyskinesia
Synchroneuron Inc.
Early research (Phase 1)Study completedNCT06216054
What this trial is testing

Safety, Tolerability and Pharmacokinetic of Multiple-ascending Doses of LPM3770164 in Healthy Subjects

Who this might be right for
Tardive DyskinesiaHuntington Disease
Luye Pharma Group Ltd. 40
Post-approval studies (Phase 4)UnknownNCT00468533
What this trial is testing

The Monitor of Serum Prolactin Level in a 3 Months Aripiprazole Trial

Who this might be right for
Schizophrenia, Tardive Dyskinesia, Metabolic Syndrome
Yu-Li Hospital 50
Testing effectiveness (Phase 2)Study completedNCT04470050
What this trial is testing

Dexmedetomidine in the Treatment of Symptoms Of Acute Opioid Withdrawal

Who this might be right for
Opioid Withdrawal
BioXcel Therapeutics Inc 225
Not applicableStudy completedNCT01467089
What this trial is testing

The Assessment of Movement Disorders Utilizing Live Two-Way Video

Who this might be right for
Tardive Dyskinesia
Northwell Health 37
Load More Results